Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 263

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Open access
Killela, Patrick J., Pirozzi, Christopher J., Healy, Patrick, Reitman, Zachary J., Lipp, Eric, Rasheed, B. Ahmed, Yang, Rui, Diplas, Bill H., Wang, Zhaohui, Greer, Paula K., Zhu, Huishan, Wang, Catherine Y., Carpenter, Austin B., Friedman, Henry, Friedman, Allan H., Keir, Stephen T., He, Jie, He, Yiping, McLendon, Roger E., Herndon, James E., Yan, Hai, Bigner, Darell D.·2014·Oncotarget
DOI 10.18632/oncotarget.1765
Open this paper in CoChat — free account

Abstract

// Patrick J. Killela 1,* , Christopher J. Pirozzi 1,* , Patrick Healy 2 , Zachary J. Reitman 1 , Eric Lipp 1 , B. Ahmed Rasheed 1 , Rui Yang 1 , Bill H. Diplas 1 , Zhaohui Wang 1 , Paula K. Greer 1 , Huishan Zhu 1 , Catherine Y. Wang 1 , Austin B. Carpenter 1 , Henry Friedman 1 , Allan H. Friedman 1 , Stephen T. Keir 1 , Jie He 3 , Yiping He 1 , Roger E. McLendon 1 , James E. Herndon II 2 , Hai Yan 1 and Darell D. Bigner 1 1 Department of Pathology, Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center at Duke, and Pediatric Brain Tumor Foundation Institute at Duke, Durham, NC, USA 2 Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA 3 Department of Thoracic Surgery, Cancer Institute and Hospital Chinese Academy of Medical Sciences, Beijing, 100021, China * Denotes equal contribution Correspondence: Hai Yan, email: // Keywords : TERT promoter, IDH1, IDH2, Glioma Received : January 26, 2014 Accepted : January 28, 2014 Published : January 28, 2014 Abstract Frequent mutations in isocitrate dehydrogenase 1 and 2 ( IDH1 and IDH2 ) and the promoter of telomerase reverse transcriptase ( TERT ) represent two significant discoveries in glioma genomics. Understanding the degree to which these two mutations co-occur or occur exclusively of one another in glioma subtypes presents a unique opportunity to guide glioma classification and prognosis. We analyzed the relationship between overall survival (OS) and the presence of IDH1/2 and TERT promoter mutations in a panel of 473 adult gliomas. We hypothesized and show that genetic signatures capable of distinguishing among several types of gliomas could be established providing clinically relevant information that can serve as an adjunct to histopathological diagnosis. We found that mutations in the TERT promoter occurred in 74.2% of glioblastomas (GBM), but occurred in a minority of Grade II-III astrocytomas (18.2%). In contrast, IDH1/2 mutations were observed in 78.4% of Grade II-III astrocytomas, but were uncommon in primary GBM. In oligodendrogliomas, TERT promoter and IDH1/2 mutations co-occurred in 79% of cases. Patients whose Grade III-IV gliomas exhibit TERT promoter mutations alone predominately have primary GBMs associated with poor median OS (11.5 months). Patients whose Grade III-IV gliomas exhibit IDH1/2 mutations alone predominately have astrocytic morphologies and exhibit a median OS of 57 months while patients whose tumors exhibit both TERT promoter and IDH1/2 mutations predominately exhibit oligodendroglial morphologies and exhibit median OS of 125 months. Analyzing gliomas based on their genetic signatures allows for the stratification of these patients into distinct cohorts, with unique prognosis and survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.1765

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 263

Metadata

Authors
Killela, P. J., Pirozzi, C. J., Healy, P., Reitman, Z. J., Lipp, E., Rasheed, B. A., Yang, R., Diplas, B. H., Wang, Z., Greer, P. K., Zhu, H., Wang, C. Y., Carpenter, A. B., Friedman, H., Friedman, A. H., Keir, S. T., He, J., He, Y., McLendon, R. E., Herndon, J. E., Yan, H., & Bigner, D. D.
Venue
Oncotarget
Publisher
Impact Journals, LLC
Published
2014-01-28
Volume
5
Issue
6
Pages
1515-1525
ISSN
1949-2553 (ISSN-L)
DOI
10.18632/oncotarget.1765
OpenAlex
W2149409455
Cited by
263
References
37
FWCI
15.90
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.